Perception of improved state of health and subjective quality of life in Crohn's disease patients treated with Infliximab

Journal of Crohn's and Colitis

Volumn 3, Issue 1, 2009, Pages 25-31

  Banovic, Ingrid ^a   Gilibert, Daniel ^b   Cosnes, Jacques ^c  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Activity of CD; Crohn's disease; Depressive mood; Infliximab; Subjective quality of life

Indexed keywords

INFLIXIMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; CROHN DISEASE; DEPRESSION; DISEASE ACTIVITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36;

EID: 58849167211     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2008.10.003     Document Type: Article

References (31)

1. Colombel J.F., Yazdanpanah Y., Laurent F., Houcke P., Delas N., and Marquis P. Qualité de vie dans les maladies inflammatoires chroniques de l'intestin. Validation d'un questionnaire et premières données françaises. Gastroenterol Clin Biol 20 12 (1996) 1071-1077
2. Graff L.A., Walker J.R., Lix L., Clara I., et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 4 (2006) 1491-1501
3. Moreno-Jiménez B., López Blanco B., Rodríguez-Muñoz A., and Garrosa Hernández. The influence of personality factors on healthrelated quality of life of patients with inflammatory bowel disease. J Psychosom Res 62 (2007) 39-46
4. Mussell M., Böcker U., Nagel N., and Singer M.V. Predictors of disease-related concerns and other aspects of health-related quality of life in out patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 16 12 (2004) 1273-1280
5. Felley C., Mottet C., Maillard M.H., Hess J., Delarive J., and Michetti P. Main therapeutic advances in IBD in 2007. Rev Med Suisse 4 141 (2008) 202-204 200, 206-208 (passim).
6. Cohen R.D. Efficacy and safety of repeated infliximab infusion for Crohn's disease: 1-year clinical experience. Inflamm Bowel Dis 7 1 (2001) S17-S22
7. Gheorghe L., Gheorghe C., Bade M., Vadan R., et al. Infliximab for Crohn's disease in clinical practice: the experience of a single center in Romania. Rom J Gastroenterol 12 1 (2003) 7-13
8. Cosnes J., Nion-Larmurier I., Beaugerie L., Afchain P., Tiret E., and Gendre J.P. Impact of the increasing use of immunosuppressants in Crohn's disease on the need of intestinal surgery. Gut 54 (2005) 237-241
9. Lindsay J., Punekar Y.S., Morris J., and Chung-Faye G. Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn's disease - modelling outcomes in active luminal and fistulizing disease in adults. Aliment Pharmacol Ther 28 1 (2008) 76-87 (Epub 2008 Apr 11).
10. Wilhelm S.M., McKenney K.A., Rivait K.N., and Kale-Pradhan P.B. A review of infliximab in ulcerative colitis. Clin Ther 30 2 (2008) 223-230
11. Casellas F., Rodrigo L., Niño P., Pantiga C., Riestra S., and Malagelada J.R. Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years. Inflamm Bowel Dis 13 11 (2007) 1395-1400
12. Guy W. Early Clinical Drug Evaluation (ECDEU) assessment manual for psychopharmacology (1976), National Institute of Mental Health, Rockville
13. Perneger T.V., Leplège A., and Etter J.F. Cross-cultural adaptation of a psychometric instrument: two methods compared. J Clin Epidemiol 52 11 (1999) 1037-1046
14. Borgaonkar M.R., and Irvine E.J. Quality of life measurement in gastrointestinal and liver disorders. Gut 47 (2000) 444-454
15. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
16. Pellet J., Decrat M., Lang F., Chazot L., et al. Description d'un échantillon de 300 échelles M.A.D.R.S. portant sur des sujets déprimés. Ann Méd Psychol 145 2 (1987) 170-175
17. Peyre F., Martinez R., Calache M., Verdoux H., and Bourgeois M. Revalidation de l'échelle de depression de Montgomery et Asberg (M.A.D.R.S.) sur un groupe de 147 patients déprimés hospitalisés. Ann Méd Psychol 147 7 (1989) 762-767
18. Lempérière T., Lépine J.P., Rouillon F., Hardy P., et al. Comparaison de différents instruments d'évaluation de la depression à l'occasion d'une etude sur l'ATHYMIL 30 mg. Ann Méd Psychol 142 (1984) 1206-1212
19. Harvey R., and Bradshaw J. A simple index of Crohn's disease activity. Lancet 1 (1980) 514
20. Siegel C.A., Levy L.C., Mackenzie T.A., and Sands B.E. Patients perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis 14 1 (2008) 1-6
21. Goff S.L., Mazor K.M., Meterko V., Dodd K., and Sabin J. Patients beliefs and preferences regarding doctors medication recommendations. J Gen Intern Med 23 3 (2008) 236-241
22. Fallowfield L., Atkins L., Catt S., Cox A., et al. Patient's preference for administration of endocrine treatments by injection or tablets: results from a study of women breast cancer. Ann Oncol 17 2 (2006) 205-210
23. Blondel-Kucharski F., Chircop C., Marquis P., Cortot A., et al. Health related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 96 (2001) 2915-2920
24. Petrak F., Hardt J., Clement T., Börner N., and Egle U.T. Impaired quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol 36 (2001) 375-382
25. Casellas F., Arenas J.I., Baudet J.S., et al. Impairment of health related quality of life in patients with inflammatory bowel disease. A Spanish multicenter study. Inflamm Bowel Dis 11 (2005) 488-496
26. Casellas F., Vivancos J.L., Sampedro M., and Malagelada J.R. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol 100 12 (2005) 2732-2742
27. Mardini H.E., Kip K.E., and Wilson J.W. Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity. Dig Dis Sci 49 3 (2004) 492-497
28. North C.S., Alpers D.H., Helzer J.E., Spitznagel E.L., and Clouse R.E. Do life events or depression exacerbate inflammatory bowel disease ? A prospective study. Ann Intern Med 114 5 (1991) 381-385
29. Guthrie E., Jackson J., Shaffer J., Thompson D., Tomenson B., and Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 97 8 (2002) 1994-1999
30. Mittermaier C., Dejaco C., Waldhoer T., Oefferlbauer-Ernst A., et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 66 (2004) 79-84
31. Porcelli P., Zaka S., Centonze S., and Sisto G. Psychological distress and levels of disease activity in inflammatory bowel disease. Ital J Gastroenterol 26 3 (1994) 111-115